Genetic variability in response to clopidogrel therapy and its clinical implications.

Abstract excerpt

This article concentrates on individual genetic differences responsible for variations of action of clopidogrel, which have been found to be partially responsible for increased cardiovascular events in patients with coronary artery disease under dual antiplatelet therapy. According to these results, genotyping for the relevant gene polymorphisms, especially for the CYP2C19 loss-of-function alleles, has been...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Aryl Hydrocarbon Hydroxylases
• Share to Clopidogrel